Absci Corporation (ABSI) vs AxoGen, Inc. (AXGN)
A side-by-side comparison of Absci Corporation and AxoGen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.40HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
AXGN
AxoGen, Inc.
$35.94HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Total return — ABSI vs AXGN
growth of $100 · dividends reinvested · last 5yABSI -46.6% (-11.8%/yr)AXGN +74.0% (+11.7%/yr)AXGN compounded faster over this window
ABSI AXGN
ABSI vs AXGN: by the numbers
- •AXGN is the larger company ($1.93B vs $1.76B market cap).
- •Both run net losses; AXGN's is the smaller (-13.36% vs -7756.37% net margin).
- •AXGN grew revenue faster over the past five years (13.99% vs -22.08% CAGR).
Metrics side by side
Valuation
| Metric | ABSI | AXGN |
|---|---|---|
| Forward P/E | N/A | 81.21 |
| P/S ratio | 1128.75 | 7.69 |
| P/B ratio | 7.16 | 7.54 |
| FCF yield | N/A | 0.13% |
Profitability
| Metric | ABSI | AXGN |
|---|---|---|
| Gross margin | -319.36% | 74.56% |
| Operating margin | -4454.21% | -5.12% |
| Net margin | -7756.37% | -13.36% |
| ROE | -49.19% | -13.09% |
| ROIC | -52.66% | -4.68% |
Growth (annualized)
| Metric | ABSI | AXGN |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | 13.99% |
| Total return CAGR (5Y) | 0.89% | 19.40% |
Frequently asked
- Which has grown faster, ABSI or AXGN?
- Over the past five years, AXGN grew revenue faster — ABSI at a -22.08% CAGR versus AXGN at 13.99%.
- How have ABSI and AXGN total returns compared?
- Over the past 5 years, ABSI delivered 0.89% and AXGN delivered 19.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Absci ROEAxoGen ROEAbsci operating marginAxoGen operating marginAbsci revenue growthAxoGen revenue growthAbsci free cash flowAxoGen free cash flow
Absci & AxoGen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.